Literature DB >> 17296806

A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells.

Wei Ju1, Xia Wang, Honglian Shi, Wenshu Chen, Steven A Belinsky, Yong Lin.   

Abstract

Nuclear factor kappaB (NF-kappaB) activated by tumor necrosis factor (TNF) attenuates the TNF-induced apoptosis pathway. Therefore, blockage of NF-kappaB should improve the anticancer activity of TNF. Luteolin, a naturally occurring polyphenol flavonoid, has been reported to sensitize colorectal cancer cells to TNF-induced apoptosis through suppression of NF-kappaB; however, the mechanisms of this effect have not been well elucidated. In this article, we provide evidence showing a critical role of reactive oxygen species (ROS) accumulation induced by luteolin in modulating TNF-activated pathways in lung cancer cells. Luteolin effectively suppressed NF-kappaB, whereas it potentiated the c-Jun N-terminal kinase (JNK) to increase apoptosis induced by TNF in lung cancer cells. Our results further demonstrate that luteolin induced an early phase ROS accumulation via suppression of the cellular superoxide dismutase activity. It is noteworthy that suppression of ROS accumulation by ROS scavengers butylated hydroxyanisole, and N-acetyl-L-cysteine prevented the luteolin-induced suppression of NF-kappaB and potentiation of JNK and significantly suppressed the synergistic cytotoxicity seen with cotreatment of luteolin and TNF. Taken together, these results suggest that the accumulation of ROS induced by luteolin plays a pivotal role in suppression of NF-kappaB and potentiation of JNK to sensitize lung cancer cells to undergo TNF-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296806     DOI: 10.1124/mol.106.032185

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  47 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death.

Authors:  Lang Bai; Shanling Xu; Wenshu Chen; Zi Li; Xia Wang; Hong Tang; Yong Lin
Journal:  Apoptosis       Date:  2011-01       Impact factor: 4.677

Review 3.  Perspectives for cancer prevention with natural compounds.

Authors:  A R M Ruhul Amin; Omer Kucuk; Fadlo R Khuri; Dong M Shin
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

4.  Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice.

Authors:  Bruna Paola Murino Rafacho; Camilla Peach Stice; Chun Liu; Andrew S Greenberg; Lynne M Ausman; Xiang-Dong Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

5.  Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.

Authors:  Debatosh Majumdar; Kyung-Ho Jung; Hongzheng Zhang; Sreenivas Nannapaneni; Xu Wang; A R M Ruhul Amin; Zhengjia Chen; Zhuo G Chen; Dong M Shin
Journal:  Cancer Prev Res (Phila)       Date:  2014-01

6.  Main constituents of polyphenol complex from seagrasses of the genus Zostera, their antidiabetic properties and mechanisms of action.

Authors:  Olga Nikolaevna Styshova; Alexander Michailovich Popov; Alexander Alekseevish Artyukov; Anna Anatolievna Klimovich
Journal:  Exp Ther Med       Date:  2017-03-10       Impact factor: 2.447

7.  Anti-hepatoma cells function of luteolin through inducing apoptosis and cell cycle arrest.

Authors:  Shixiong Ding; Airong Hu; Yaoren Hu; Jianbo Ma; Pengjian Weng; Jinhua Dai
Journal:  Tumour Biol       Date:  2013-11-28

Review 8.  The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.

Authors:  Yong Lin; Lang Bai; Wenjie Chen; Shanling Xu
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

Review 9.  Tumor necrosis factor and cancer, buddies or foes?

Authors:  Xia Wang; Yong Lin
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

Review 10.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.